Reaction

Migraine With Aura reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,678 reports · 61 co-occurring drugs

As of the last recalculation, Migraine With Aura appears in 2,678 FAERS reports alongside 61 co-occurring drug terms. The strongest observed disproportionality signal is RABEPRAZOLE (PRR 18.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Rabeprazole	53	18.9	19.0
Rizatriptan Benzoate	20	15.4	15.4
Sumatriptan Succinate	46	14.4	14.4
Romiplostim	27	14.1	14.1
Sumatriptan	66	13.8	13.8
Captopril	15	12.2	12.2
Erenumab-Aooe	80	11.6	11.6
Sevoflurane	12	11.3	11.3
Galcanezumab-Gnlm	44	11.0	11.0
Etonogestrel And Ethinyl Estradiol	31	11.0	11.0
Fremanezumab-Vfrm	16	10.9	10.9
Dexamethasone Sodium Phosphate	14	10.8	10.8
Indomethacin	18	10.6	10.6
Felodipine Extended-Release Tablets	15	10.3	10.3
Felodipine	15	10.3	10.3
Rabeprazole Sodium	35	10.1	10.1
Rimegepant Sulfate	16	9.9	9.9
Butalbital, Acetaminophen, And Caffeine	13	9.5	9.5
Botulinum Toxin Type A	15	9.4	9.4
Amitriptyline Hydrochloride	21	9.4	9.4
Propranolol Hydrochloride	83	9.2	9.2
Topiramate	106	9.2	9.2
Nebivolol	17	8.3	8.3
Drospirenone And Ethinyl Estradiol	44	7.9	7.9
Ketoprofen	13	7.7	7.7
Eptinezumab-Jjmr	9	7.7	7.7
Fexofenadine	14	6.6	6.6
Acetaminophen, Aspirin (Nsaid) And Caffeine	13	6.0	6.0
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	26	5.8	5.8
Fingolimod Hcl	60	5.5	5.5
Calcium, Magnesium, Potassium, And Sodium Oxybates	6	5.4	5.4
Nebivolol Hydrochloride	23	5.3	5.3
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	28	5.3	5.3
Acetaminophen, Aspirin, And Caffeine	14	5.2	5.2
Diclofenac Sodium 1%	23	5.0	5.0
Diclofenac Sodium Topical	23	5.0	5.0
Diclofenac Sodium Topical Gel, 1%	23	5.0	5.0
Estradiol	53	4.8	4.8
Levonorgestrel	119	4.8	4.8
Vincristine Sulfate	17	4.5	4.5
Estradiol Gel 0.1%	26	4.5	4.5
Estradiol Transdermal	26	4.5	4.5
Sodium Oxybate	37	4.4	4.4
Atomoxetine Hydrochloride	13	4.3	4.3
Loratadine Tablet	28	4.1	4.1
Bimatoprost	15	4.1	4.1
Ozanimod Hydrochloride	4	3.7	3.7
Onabotulinumtoxina	32	3.2	3.3
Asfotase Alfa	4	3.1	3.1
Mometasone Furoate And Formoterol Fumarate Dihydrate	6	3.0	3.0
Benralizumab	7	2.7	2.7
Belimumab	11	2.7	2.7
Rucaparib	3	2.6	2.6
Diroximel Fumarate	4	2.6	2.6
Etonogestrel	12	2.0	2.0
Elexacaftor, Tezacaftor, And Ivacaftor	3	1.9	1.9
Aflibercept	7	1.7	1.7
Abaloparatide	5	1.3	1.3
Evolocumab	21	1.0	1.0
Tirzepatide	17	0.8	0.8
Adapalene	4	0.2	0.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.